Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1.
Signal Transduct Target Ther. 2024 Mar 6;9(1):54. doi: 10.1038/s41392-024-01758-8.
Signal Transduct Target Ther. 2024.
PMID: 38443334
Free PMC article.
A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike protein.
Xue S, Wang X, Wang L, Xu W, Xia S, Sun L, Wang S, Shen N, Yang Z, Huang B, Li S, Cao C, Calcul L, Sun X, Lu L, Cai J, Jiang S.
Xue S, et al.
Cell Discov. 2022 Sep 8;8(1):88. doi: 10.1038/s41421-022-00455-6.
Cell Discov. 2022.
PMID: 36075899
Free PMC article.
Item in Clipboard
Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation.
Hua C, Ma Q, Zhu Y, Xia S, Liu Z, Li L, Lu L, Zhong N, Liu S, Yang Z, Jiang S.
Hua C, et al.
Signal Transduct Target Ther. 2021 Aug 26;6(1):318. doi: 10.1038/s41392-021-00737-7.
Signal Transduct Target Ther. 2021.
PMID: 34446694
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite